The effect of food on ritonavir bioavailability following administration of ritonavir 100 mg film-coated tablet in healthy adult subjects
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-2652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The effect of food on ritonavir bioavailability following administration of ritonavir 100 mg film-coated tablet in healthy adult subjects ; volume:11 ; number:1 ; day:10 ; month:11 ; year:2008 ; pages:1-2 ; date:12.2008
Journal of the International AIDS Society / International AIDS Society ; 11, Heft 1 (10.11.2008), 1-2, 12.2008
- Creator
-
Ng, J.
- Contributor
-
Klein, CE
Chui, YL
Awni, WM
Morris, JB
Podsadecki, TJ
Cui, Y.
Bernstein, B.
Kim, D.
SpringerLink (Online service)
- DOI
-
10.1186/1758-2652-11-S1-P247
- URN
-
urn:nbn:de:1111-2016052056922
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ng, J.
- Klein, CE
- Chui, YL
- Awni, WM
- Morris, JB
- Podsadecki, TJ
- Cui, Y.
- Bernstein, B.
- Kim, D.
- SpringerLink (Online service)
Other Objects (12)
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir
Nirmatrelvir Plus Ritonavir: First Approval
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
Lopinavir/ritonavir monotherapy in clinical practice
Scutellaria baicalensis decreases ritonavir-induced nausea
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Pharmakokinetik der Protease-Inhibitoren Lopinavir und Ritonavir
Correction to: Nirmatrelvir Plus Ritonavir: First Approval
Ombitasvir/Paritaprevir/Ritonavir: Nutzenbewertung gemäß § 35a SGB V
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Ritonavir plus Saquinavir bei HIV-infizierten Patienten mit virologischem Therapieversagen einer Kombinationstherapie unter Einschluß von Indinavir, Ritonavir oder Saquinavir plus Nelfinavir
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir
Nirmatrelvir Plus Ritonavir: First Approval
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
Lopinavir/ritonavir monotherapy in clinical practice
Scutellaria baicalensis decreases ritonavir-induced nausea
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Pharmakokinetik der Protease-Inhibitoren Lopinavir und Ritonavir
Correction to: Nirmatrelvir Plus Ritonavir: First Approval
Ombitasvir/Paritaprevir/Ritonavir: Nutzenbewertung gemäß § 35a SGB V
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Ritonavir plus Saquinavir bei HIV-infizierten Patienten mit virologischem Therapieversagen einer Kombinationstherapie unter Einschluß von Indinavir, Ritonavir oder Saquinavir plus Nelfinavir
Population pharmacokinetic/pharmacodynamic analysis of lopinavir and ritonavir in subjects receiving the tablet formulation
Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir
Nirmatrelvir Plus Ritonavir: First Approval
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
Lopinavir/ritonavir monotherapy in clinical practice
Scutellaria baicalensis decreases ritonavir-induced nausea
Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
Pharmakokinetik der Protease-Inhibitoren Lopinavir und Ritonavir
Correction to: Nirmatrelvir Plus Ritonavir: First Approval
Ombitasvir/Paritaprevir/Ritonavir: Nutzenbewertung gemäß § 35a SGB V
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir